Search results
Results from the WOW.Com Content Network
That’s about half of the biotech industry’s projected earnings growth rate but slightly higher than the U.S. market average earnings growth rate. ... Information is accurate as of Sept. 9, 2022.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This is a list of emerging technologies, which are in-development technical innovations that have significant potential in their applications. The criteria for this list is that the technology must: Exist in some way; purely hypothetical technologies cannot be considered emerging and should be covered in the list of hypothetical technologies ...
Alnylam (ALNY): pioneering a new class of therapeutics based on RNA interference and a better fit for collaboration partner Novartis (NYSE:NVS) BioMarin (NASDAQ:BMRN): a rare disease gene therapy ...
They're both innovative biotechs working in relatively newer niches of this booming industry. However, they've moved in the wrong direction this year. CRISPR's shares are down by 27% year to date ...
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Biotech stocks have a reputation as a high-risk investment. However, a bear market represents a good time to take a chance on these biotech stocks. 7 Best Biotech Stocks To Add to Your Portfolio ...